Scientific Opinion on the substantiation of health claims related to resistant maltodextrin and reduction of post prandial glycaemic responses (ID 796), maintenance of normal blood LDL cholesterol concentrations (ID 2927), maintenance of normal (fasting) blood concentrations of triglycerides (ID 2927) and changes in bowel function (ID 797) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Published:
Adopted:
EFSA Journal logo
Wiley Online Library
Full article:

Meta data

DOI
https://doi.org/10.2903/j.efsa.2011.2070
Keywords
Resistant maltodextrin, glycaemic responses, LDL cholesterol, triglycerides, bowel function, health claims
On request from
European Commission
Question Number
EFSA-Q-2008-1583
EFSA-Q-2008-1584
EFSA-Q-2008-3660
Panels
Nutrizione, nuovi alimenti e allergeni alimentari
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Contact
nda@efsa.europa.eu

Abstract

No abstract available
© European Food Safety Authority, 2011
Prodotti dietetici, nutrizione umana e allergie